Mohamed Genead
Director Ejecutivo en Aviceda Therapeutics, Inc. .
Cargos activos de Mohamed Genead
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Fundador | - | - | |
| Presidente | - | - | |
| Secretario Corporativo | - | - | |
| Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Director Ejecutivo | - | - |
| Presidente | - | - | |
| Director Financiero/CFO | - | - | |
| Presidente | - | - | |
| Secretario Corporativo | - | - |
Historial de carrera de Mohamed Genead
Antiguos cargos conocidos de Mohamed Genead.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Director Técnico/Científico/I+D | 01/05/2017 | 01/11/2017 |
| University of Illinois | Corporate Officer/Principal | - | - |
| OCUGEN, INC. | Director Técnico/Científico/I+D | - | - |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Francia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Bolsa de valores
- Insiders
- Mohamed Genead
- Experiencia
